Viewing StudyNCT06315205



Ignite Creation Date: 2024-05-06 @ 8:15 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06315205
Status: RECRUITING
Last Update Posted: 2024-03-19
First Post: 2024-03-11

Brief Title: Evaluation of the Pharmacokinetics Safety and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women
Sponsor: Rovi Pharmaceuticals Laboratories
Organization: Rovi Pharmaceuticals Laboratories

Conditions & Keywords Data

Conditions:
Name
Healthy
Keywords:
Name View
Breast cancer View
Pharmacokinetics View
Safety View
Letrozol LEBE View
Intramuscular View